SAN DIEGO, Aug. 4, 2020 /PRNewswire/ — HUYA Bioscience International (HUYABIO
®
), the leader in accelerating global development of China’s pharmaceutical innovations, announced today it has exclusively licensed worldwide rights, … […]
— Test gives simple positive or negative color change results in 30 minutes or less– No special laboratory equipment required, hence practical for on-site deployment– Test uses saliva, eliminating need for painful nasal swabbing– Study shows sensit… […]
RAS is the most common oncogene implicated in human cancerKRAS, HRAS or NRAS mutations are present in approximately one-third of all cancer patients
CARLSBAD, Calif. , July 22, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen… […]
SciClone granted exclusive license to co-develop and commercialize RRx-001 upon approval in the Greater China Region
LA JOLLA, Calif., July 1, 2020 /PRNewswire/ — EpicentRx Inc. (“EpicentRx”), a San Diego-based clinical cancer immunotherapy company … […]
CARLSBAD, Calif., June 10, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today the signing of an exclusive license agreement with the University of Louisville (UofL) to facilitate developme… […]
CARLSBAD, Calif., June 2, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the Company has released a pre-launch supply of its proposed FastPack® SARS-CoV-2 IgG Immunoassay diagnostic tes… […]
Multi-Target Collaboration Leverages Vividion’s Screening Platform to Discover and Develop Highly Selective Small Molecules for E3 Ligases and Select Oncology and Immunology TargetsVividion Receives $135 Million Upfront Payment With Potential for Multi… […]
SAN CARLOS, Calif. and SAN DIEGO, May 18, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, and Illumina Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing platforms, today announ… […]
SAN DIEGO, May 5, 2020 /PRNewswire/ –?Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing services agr… […]
– Janssen’s DARZALEX FASPRO(TM) is a subcutaneous co-formulation of DARZALEX? and Halozyme’s ENHANZE? technology — Innovative, fixed-dose formulation demonstrates consistent efficacy to intravenous DARZALEX? with lower rate of infusion-related reactio… […]
Increases database of RRIDs for bioscience researchers exponentially
SAN DIEGO, April 27, 2020 /PRNewswire/ — SciCrunch’s Antibody Registry announced this week that it has partnered with ChromoTek to assign unique identifiers (RRIDs) to ChromoTek’s … […]
-Forge is eligible to receive $190.5M in total payments-
SAN DIEGO, March 25, 2020 /PRNewswire/ — Forge Therapeutics, Inc. (Forge) announced today that they have entered into a research collaboration and option agreement with Hoffmann-La Roche Ltd. … […]